Akebia Therapeutics' Vafseo adoption accelerates, but profitability remains distant amid Auryxia's decline. Read why AKBA ...
Obsidian Entertainment saw its share of layoffs and is going through massive changes, one of which reportedly involves making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results